Leo Pharma
Trending Articles
Related Content
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Research & Development
Drug approvals: more numerous but niche
After many years of low approval rates, in 2012 more than 30 new drugs were approved by the European Medicines Agency. Although many of them were niche products, some were for diseases with large patient populations, such as diabetes and various forms of cancer